Roche Latvija SIA is a biotech company. The company develops and manufactures specialized medications for the treatment of various diseases, including oncology, immune, infectious diseases, ophthalmology, and diseases of the central nervous system. Roche operates in over 100 countries and had a turnover of EUR 47.12 billion in 2016. They claim to promote and support the development of new and innovative ideas, as well as research in certain areas of healthcare and the creation of products or services. Roche has a broad range of products in the area of eye clinic and strives to develop the right method of therapy for each patient by making innovative scientific discoveries and offering personalized healthcare. They are also involved in research and development for the treatment of lung cancer and have established an Innovation Incubator to promote and support the development of innovative ideas, products, and services in the healthcare field.
Headquarters
Miera iela 25
Riga; Riga;
Postal Code: 1001
Contact Details: Purchase the Roche Latvija SIA report to view the information.
Website: http://www.roche.lv
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service